Search results for "COVID-19 infection"

showing 3 items of 3 documents

Determinants of COVID-19 Vaccine Rollouts and Their Effects on Health Outcomes

2022

Background Vaccination against the coronavirus disease (SARS-CoV-2) is understood to be the key way out of the COVID-19 pandemic. Limited evidence exists on the determinants of vaccine rollouts and their health effects at the country level. Objective Examine the determinants of COVID-19 vaccine rollouts and their effects on health outcomes. Methods Ordinary least squares regressions with standard errors clustered at the country level for Cross-section and Panel daily data of vaccinations and various health outcomes (new COVID-19 cases, fatalities, intensive care unit (ICU) admissions) for an unbalanced sample of about 200 countries during the period 16 December 2020 to 20 June 2021. Results…

Economics and Econometricsand (iii) COVID-19 cases in neighboring countries can lead to an increase in a country's domestic caseload and hamper efforts in taming its own local outbreak. Conclusions: By providing an early broad overview of the quantitative empirical estimates of the determinants of vaccine rollouts and the effects of COVID-19 vaccines our paper can help policymakers make informed decisions about local and global distributions of vaccines as well as related policy tools such as containment measure.Coronavirus disease 2019 (COVID-19)business.industryHealth PolicyNational accountsOutbreakGeneral Medicine(ii) vaccine deployment significantly reduces new COVID-19 infections Intensive Care Unit (ICU) admissions and fatalities and is more effective when coupled with stringent containment measures or when a country is experiencing a large outbreakVaccination against the coronavirus disease (SARS-CoV-2) is understood to be the key way out of the COVID-19 pandemic. Limited evidence exists on the determinants of vaccine rollouts and their health effects at the country level. Objective: Examine the determinants of COVID-19 vaccine rollouts and their effects on health outcomes. Methods: Ordinary least squares regressions with standard errors clustered at the country level for Cross-section and Panel daily data of vaccinations and various health outcomes (new COVID-19 cases fatalities intensive care unit (ICU) admissions) for an unbalanced sample of about 200 countries during the period 16 December 2020 to 20 June 2021. Results: We find evidence that: (i) early vaccine procurement domestic production of vaccines the severity of the pandemic a country's health infrastructure and vaccine acceptance are significant determinants of the speed of vaccination rolloutHealth outcomesIntensive care unitlaw.inventionVaccinationProcurementlawEnvironmental healthPandemicGeneral Earth and Planetary SciencesMedicinebusinessGeneral Environmental ScienceIMF Working Papers
researchProduct

Utility of lateral flow tests in SARS-CoV-2 infection monitorization

2020

Introduction. The diagnosis of SARS-CoV-2 infection is crucial for medical and public health reasons, to allow the best treatment of cases and the best control of the pandemic. Serology testing allows for the detection of asymptomatic infections and 19-COVID cases once the virus has been cleared. We analyzed the usefulness of the SARS-CoV-2 rapid test of Autobio and tried to correlate its pattern with the severity of COVID19 infection. Material and methods. We analyzed the accuracy and clinical usefulness of a point-of-care IgM and/or IgG test for SARS-CoV-2 in 35 COVID-19 patients [12 (34.3%) mild-moderate and 23 (65.7%) severe-critical] admitted to a field hospital in Madrid, as well as i…

Malebandas débilmente positivas0301 basic medicineTime FactorsOriginalCross-sectional studyinfección por COVID-19weak positive bandsDiseaseAntibodies ViralSeverity of Illness IndexSerologyCOVID-19 Testing0302 clinical medicineSerologic rapid tests030212 general & internal medicineAsymptomatic InfectionsImmunoassaybiologyReverse Transcriptase Polymerase Chain ReactionGeneral MedicineMiddle AgedPoint-of-Care TestingFemaleSymptom Assessmentmedicine.symptomAntibodyCoronavirus InfectionsAdultMicrobiology (medical)medicine.medical_specialtyPoint-of-care testingPneumonia ViralSensitivity and SpecificityAsymptomaticVirusBetacoronavirus03 medical and health sciencesInternal medicineSeverity of illnessmedicineHumanstest serológicos rápidosPandemicsAgedPharmacologyClinical Laboratory TechniquesSARS-CoV-2business.industryCOVID-19COVID-19 infectionCross-Sectional Studies030104 developmental biologyImmunoglobulin MAutobioImmunoglobulin Gbiology.proteinbusinessRevista Española de Quimioterapia
researchProduct

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNI…

2020

International audience; Introduction - Patients treated for malignancy are considered at risk of severe COVID-19. This exceptional pandemic has affected countries on every level, particularly health systems which are experiencing saturation. Like many countries, France is currently greatly exposed, and a complete reorganization of hospitals is ongoing. We propose here adaptations of diagnostic procedures, therapies and care strategies for patients treated for digestive cancer during the COVID-19 epidemic. Methods - French societies of gastroenterology and gastrointestinal (GI) oncology carried out this study to answer two main questions that have arisen (i) how can we limit high-risk situat…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralDigestive cancerMEDLINEAntineoplastic AgentsFrench Clinical Practice Guidelines[SDV.CAN]Life Sciences [q-bio]/CancerComorbidityMalignancyBetacoronavirus03 medical and health sciences0302 clinical medicineHealth carePandemicDisease Transmission InfectiousHumansChemotherapyMedicineInfection controlIntensive care medicinePandemicsDigestive System Surgical ProceduresSocieties MedicalGastrointestinal NeoplasmsInfection ControlHepatologySARS-CoV-2business.industryGastroenterologyCOVID-19Evidence-based medicinemedicine.diseaseComorbidityPatient Care ManagementCOVID-19 infection3. Good health030220 oncology & carcinogenesisSurgery030211 gastroenterology & hepatologyFranceCoronavirus InfectionsbusinessDigestive and Liver Disease
researchProduct